BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Wake Forest University School of Medicine Develops Digital Platform to Better Care for Stroke Patients
August 9, 2022: Pappas managed Catalyst Fund provides funding to develop Wake Forest University School of Medicine digital platform.
